1-cyclopentyl-3-(3,5-dinitrophenyl)-2H-imidazole

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-cyclopentyl-3-(3,5-dinitrophenyl)-2H-imidazole
• 化学式: C14H16N4O4
• 分子量: 304.3
• InChiKey: XPUWPNFZLCGBNB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  98.1
• 氢给体数：
  0
• 氢受体数：
  6

文献信息

• Process for Preparing Asymmetrical Imidazolium Salts
  申请人：ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES

  公开号：US20150329494A1

  公开（公告）日：2015-11-19

  The invention relates to a process for preparing an asymmetrical imidazolium salt of formula (1A), in which R1 is an aromatic group, R2 is chosen from a cyclic secondary aliphatic alkyl group and a heteroalkyl group, R3 and R4 are chosen, independently of one another, from the group consisting of hydrogen, a halide and an alkyl group, and A″ is an anion. The process comprises a fast substep of forming a reaction mixture by bringing one equivalent of an aniline into contact with one equivalent of a compound bearing an amine group, in the presence of at least four point five equivalents of a Brønsted acid. The process also comprises a second substep of forming a solution comprising one equivalent of a dicarbonyl, one equivalent of formaldehyde, and at least four point five equivalents of the Brønsted acid, and adding thereto the reaction mixture formed in the first substep. The mixture is left to stir for a predetermined time at a predetermined temperature. The intermediate asymmetrical imidazolium salt 1A is then isolated.

  该发明涉及一种制备不对称咪唑盐的过程，其化学式为(1A)，其中R1是芳香族基，R2选择自环状次生脂肪烷基和杂原子烷基，R3和R4分别选择自氢、卤素和烷基组成的基团，A″是阴离子。该过程包括以下步骤：通过将一当量的苯胺与带有胺基的化合物接触，在至少四点五当量的布朗斯特酸存在下形成反应混合物的快速子步骤。该过程还包括形成溶液的第二子步骤，该溶液包含一当量的二羰基化合物、一当量的甲醛和至少四点五当量的布朗斯特酸，并将第一子步骤形成的反应混合物加入其中。将混合物在预定时间和预定温度下搅拌，然后分离得到中间体不对称咪唑盐1A。
• Ruthenium Complexes Comprising an Asymmetrical Unsaturated N-Heterocyclic Diaminocarbene
  申请人：ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES

  公开号：US20150315223A1

  公开（公告）日：2015-11-05

  The invention relates to a ruthenium alkylidene complex comprising a 1-aryl-3-cycloalkyl-imidazolin-2-ylidene ligand, the cycloalkyl group of said 1-aryl-3-cycloalkyl-imidazolin-2-ylidene ligand being a cyclic secondary aliphatic alkyl.

  本发明涉及一种含有1-芳基-3-环烷基-咪唑啉-2-基膦配体的钌烯烃配合物，其中所述1-芳基-3-环烷基-咪唑啉-2-基膦配体的环烷基为环状二级脂肪基。
• US9688641B2
  申请人：——

  公开号：US9688641B2

  公开（公告）日：2017-06-27
• US9776178B2
  申请人：——

  公开号：US9776178B2

  公开（公告）日：2017-10-03
• [EN] RUTHENIUM COMPLEXES COMPRISING AN ASYMMETRICAL UNSATURATED N-HETEROCYCLIC DIAMINOCARBENE<br/>[FR] COMPLEXES DE RUTHENIUM COMPRENANT UN DIAMINOCARBENE N-HETEROCYCLIQUE INSATURE DISSYMETRIQUE
  申请人：ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES

  公开号：WO2014091157A1

  公开（公告）日：2014-06-19

  L'invention vise un complexe de ruthénium alkylidène comprenant un ligand l-aryl-3- cycloalkyl-imidazoline-2-ylidene, le groupement cycloalkyle dudit ligand l-aryl-3-cycloalkyl- imidazoline-2-ylidene étant un alkyle aliphatique secondaire cyclique.